EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT

EyePoint Pharmaceuticals (EYPT) Cash flow

773 Followers

EyePoint Pharmaceuticals Cash Flow

EYPT's free cash flow for Q1 2024 was $-32.37M. For the 2024 fiscal year, EYPT's free cash flow was decreased by $65.55M and operating cash flow was $-31.17M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -6.19M$ 1.88M$ -65.00M$ -50.06M$ -14.44M$ -56.70M
Investing Cash Flow
$ 64.64M$ -3.31M$ -17.27M$ -33.12M$ -362.00K$ -213.00K
Financing Cash Flow
$ -31.30M$ 187.07M$ -690.00K$ 216.90M$ 37.49M$ 33.86M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 650.01M$ 281.41M$ 95.83M$ 178.78M$ 45.06M$ 22.36M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 1.41M$ 1.41M$ 2.60M$ 4.85M$ 5.51M$ 4.87M
Issuance Of Capital Stock
$ 9.97M$ 226.17M--$ 49.92M$ 22.63M
Issuance Of Debt
$ -40.51M$ -40.51M$ 2.10M$ -146.00K$ 2.04M$ 50.00M
Repayment Of Debt
$ -45.81M$ -45.81M$ -71.77M$ -146.00K$ -13.84M$ -20.00M
Free Cash Flow
$ -9.98M$ -1.61M$ -67.16M$ -50.21M$ -14.80M$ -56.91M
Domestic Sales
------
Foreign Sales
------
Currency in USD

EyePoint Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis